» Articles » PMID: 15684039

CD25+ CD4+ T Cells Compete with Naive CD4+ T Cells for IL-2 and Exploit It for the Induction of IL-10 Production

Overview
Journal Int Immunol
Date 2005 Feb 3
PMID 15684039
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Maintenance of homeostasis in the immune system involves competition for resources between T lymphocytes, which avoids the development of immune pathology seen in lymphopenic mice. CD25+ CD4+ T cells are important for homeostasis, but there is as yet no consensus on their mechanisms of action. Although CD25+ CD4+ T cells cause substantial down-regulation of IL-2 mRNA in responder T cells in an in vitro co-culture system, the presence of IL-protein can be demonstrated by intracellular staining. As a consequence of competition for IL-2, CD25+ CD4+ T cells further up-regulate the IL-2R alpha chain (CD25), a process that is strictly dependent on IL-2, whereas responder T cells fail to up-regulate CD25. Similarly, adoptive transfer into lymphopenic mice showed that CD25+ CD4+ T cells interfere with CD25 up-regulation on co-transferred naive T cells, while increasing their own CD25 levels. IL-2 sequestration by CD25+ CD4+ T cells is not a passive phenomenon but instead initiates--in conjunction with signals through the TCR--their differentiation to IL-10 production. Although IL-10 is not required for in vitro suppression, it is vital for the in vivo function of regulatory T cells. Our data provide a link explaining the apparent difference in regulatory mechanisms in vitro and in vivo.

Citing Articles

CD137-expressing regulatory T cells in cancer and autoimmune diseases.

Lee K, Mei Y, Liu H, Schwarz H Mol Ther. 2024; 33(1):51-70.

PMID: 39668561 PMC: 11764688. DOI: 10.1016/j.ymthe.2024.12.010.


Tregs in transplantation tolerance: role and therapeutic potential.

Cassano A, Chong A, Alegre M Front Transplant. 2024; 2:1217065.

PMID: 38993904 PMC: 11235334. DOI: 10.3389/frtra.2023.1217065.


Adjusting to self in the thymus: CD4 versus CD8 lineage commitment and regulatory T cell development.

Baldwin I, Robey E J Exp Med. 2024; 221(10).

PMID: 38980291 PMC: 11232887. DOI: 10.1084/jem.20230896.


Mechanisms underlying immunosuppression by regulatory cells.

Goldmann O, Nwofor O, Chen Q, Medina E Front Immunol. 2024; 15:1328193.

PMID: 38380317 PMC: 10876998. DOI: 10.3389/fimmu.2024.1328193.


Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology.

Elemam N, Mekky R, Rashid G, Braoudaki M, Youness R Expert Rev Mol Med. 2024; 26:e1.

PMID: 38186186 PMC: 10941350. DOI: 10.1017/erm.2023.26.